DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

ResMed Q2 EPS $1.21 Beats $1.03 Estimate, Sales $736.2M Beat $731.58M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.03 by 17.48 percent. This is a 21 percent increase over earnings of $1 per share from the same period last

Benzinga · 01/30/2020 21:08

ResMed (NYSE:RMD) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.03 by 17.48 percent. This is a 21 percent increase over earnings of $1 per share from the same period last year. The company reported quarterly sales of $736.2 million which beat the analyst consensus estimate of $731.58 million by 0.63 percent. This is a 13.07 percent increase over sales of $651.1 million the same period last year.